Polypeptide N-acetylgalactosaminyltransferase 2
The GALNT2 gene encodes an enzyme responsible for O-glycosylation in the Golgi apparatus. APOC3, LDLR, and VLDLR are O-glycosylated. Genetic variations in that gene are associated with type 2 diabetes and familial combined hyperlipidemia.
Genetests:
Research |
Method |
Carrier testing |
Turnaround |
5 days |
Specimen type |
genomic DNA |
Related Diseases:
References:
1. |
Teslovich TM et al. (2010) Biological, clinical and population relevance of 95 loci for blood lipids.
|
2. |
Cefalù AB et al. () Identification of a novel LMF1 nonsense mutation responsible for severe hypertriglyceridemia by targeted next-generation sequencing.
|
3. |
Weissglas-Volkov D et al. (2010) Investigation of variants identified in caucasian genome-wide association studies for plasma high-density lipoprotein cholesterol and triglycerides levels in Mexican dyslipidemic study samples.
|
4. |
Bennett EP et al. (1998) Genomic organization and chromosomal localization of three members of the UDP-N-acetylgalactosamine: polypeptide N-acetylgalactosaminyltransferase family.
|
5. |
White T et al. (1995) Purification and cDNA cloning of a human UDP-N-acetyl-alpha-D-galactosamine:polypeptide N-acetylgalactosaminyltransferase.
|
6. |
Cheng L et al. (2004) Characterization of a novel human UDP-GalNAc transferase, pp-GalNAc-T15.
|
7. |
Peng C et al. (2010) Identification of a novel human UDP-GalNAc transferase with unique catalytic activity and expression profile.
|
8. |
Khetarpal SA et al. (2016) Loss of Function of GALNT2 Lowers High-Density Lipoproteins in Humans, Nonhuman Primates, and Rodents.
|
9. |
NCBI article
NCBI 2590
|
10. |
OMIM.ORG article
Omim 602274
|
11. |
Wikipedia article
Wikipedia EN (GALNT2)
|
Update: Aug. 14, 2020